JAZZ Financial Facts

Total revenues: 374.18M
Intangible asset amortization: 26.45M
See Full Income Statement

See Full Balance Sheet

Jazz Pharmaceuticals, Inc. (JAZZ) Earnings

  |   Expand Research on JAZZ
Next EPS Date 2/22/17 *Est. EPS Growth Rate +2.0% *Last Qtr.
Average EPS % Beat Rate -2.4% Revenue Growth Rate +9.7% *Last Qtr.
Average % Move 1-Wk after EPS -0.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/4/10 Q310 $0.41$0.34 +$0.07N/AN/A N/A Details
3/7/11 Q410 $0.63$0.60 +$0.03$53.4M$51.05M Details
11/5/13 Q313 $1.78$1.67 +$0.11$232.2M$227.38M = Details
11/8/16 Q316 $2.57$2.61 -$0.04$374M$389.23M = Details
8/6/13 Q213 $1.43$1.52 -$0.09$208.3M$208.71M = Details
2/26/13 Q412 $1.53$1.42 +$0.11$183.7M$183.8M = Details
7/28/11 Q211 $0.82$0.77 +$0.05$64.6M$61.86M Details
11/4/14 Q314 $2.33$2.23 +$0.10$306.6M$302.9M Details